The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
Open accessAbstract
Adoptive transfer of chimeric antigen receptor (CAR)-redirected T lymphocytes (CAR-T cells) has had less striking therapeutic effects in solid tumors than in lymphoid malignancies. Although active tumor-mediated immunosuppression may have a role in limiting the efficacy of CAR-T cells, functional changes in T lymphocytes after their ex vivo manipulation may also account for the reduced ability of cultured CAR-T cells to penetrate stroma-rich solid tumors compared with lymphoid tissues. We therefore studied the capacity of human in vitro–cultured CAR-T cells to degrade components of the extracellular matrix (ECM). In contrast to freshly isolated T lymphocytes, we found that in vitro–cultured T lymphocytes lack expression of the enzyme heparanase (HPSE), which degrades heparan sulfate proteoglycans, the main components of ECM. We found that HPSE mRNA is downregulated in in vitro–expanded T cells, which may be a consequence of p53 (officially known as TP53, encoding tumor protein 53) binding to the HPSE gene promoter. We therefore engineered CAR-T cells to express HPSE and showed their improved capacity to degrade the ECM, which promoted tumor T cell infiltration and antitumor activity. The use of this strategy may enhance the activity of CAR-T cells in individuals with stroma-rich solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005930 · Cited by 2,063
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
Iozzo, R. V. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.609 · Cited by 1,637
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
Kershaw, M. H., Westwood, J. A., Parker, L. L., Wang, G., Eshhar, Z., Mavroukakis, S. A., White, D. E., Wunderlich, J. R., Canevari, S., Rogers-Freezer, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1183 · Cited by 1,254
Pule, M. A., Savoldo, B., Myers, G. D., Rossig, C., Russell, H. V., Dotti, G., Huls, M. H., Liu, E., Gee, A. P., Mei, Z., et al. (2008) · Nature Medicine · doi:10.1038/nm.1882 · Cited by 1,195
Self-citationSavoldo, B., Ramos, C. A., Liu, E., Mims, M. P., Keating, M. J., Carrum, G., Kamble, R. T., Bollard, C. M., Gee, A. P., Mei, Z., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46110 · Cited by 1,023
Self-citationMolecular architecture of basement membranes
Yurchenco, P. D., & Schittny, J. C. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.6.2180767 · Cited by 944
Leukocyte–endothelial-cell interactions in leukocyte transmigration and the inflammatory response
Muller, W. A. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00117-0 · Cited by 823
Craddock, J. A., Lu, A., Bear, A., Pule, M., Brenner, M. K., Rooney, C. M., & Foster, A. E. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181ee6675 · Cited by 513
The role of heparan sulphate in inflammation
Parish, C. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1918 · Cited by 495
Pulè, M. A., Straathof, K. C., Dotti, G., Heslop, H. E., Rooney, C. M., & Brenner, M. K. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.016 · Cited by 487
Self-citationActivated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase
Naparstek, Y., Cohen, I. R., Fuks, Z., & Vlodavsky, I. (1984) · Nature · doi:10.1038/310241a0 · Cited by 346
Heparan sulfate: growth control with a restricted sequence menu
Gallagher, J. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13713 · Cited by 319
Vlodavsky, I., Eldor, A., Haimovitz‐Friedman, A., Matzner, Y., Ishai-Michaeli, R., Lider, O., Naparstek, Y., Cohen, I. R., & FUKS, Z. Y. (1992) · PubMed · Cited by 302
Vlodavsky, I., Ilan, N., Naggi, A., & Casu, B. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781039742 · Cited by 276
Vera, J., Savoldo, B., Vigouroux, S., Biagi, E., Pule, M., Rossig, C., Wu, J., Heslop, H. E., Rooney, C. M., Brenner, M. K., et al. (2006) · Blood · doi:10.1182/blood-2006-04-017061 · Cited by 275
Self-citationNakajima, M., Irimura, T., Di Ferrante, N., & Nicolson, G. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43350-3 · Cited by 266
Naggi, A., Casu, B., Perez, M., Torri, G., Cassinelli, G., Penco, S., Pisano, C., Giannini, G., Ishai-Michaeli, R., & Vlodavsky, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414217200 · Cited by 229
p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes
Mondal, A. M., Horikawa, I., Pine, S. R., Fujita, K., Morgan, K. M., Vera, E., Mazur, S. J., Appella, E., Vojtesek, B., Blasco, M. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70355 · Cited by 164
Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
Yvon, E. S., Vecchio, M. D., Savoldo, B., Hoyos, V., Dutour, A., Anichini, A., Dotti, G., & Brenner, M. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3163 · Cited by 141
Self-citationGeldres, C., Savoldo, B., Hoyos, V., Caruana, I., Zhang, M., Yvon, E. S., Vecchio, M. D., Creighton, C. J., Ittmann, M., Ferrone, S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2218 · Cited by 101
Self-citationMigration of leukocytes through the vessel wall and beyond
Yadav, R., Larbi, K. Y., Young, R., & Nourshargh, S. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-04-0220 · Cited by 100
Tumor suppressor p53 regulates heparanase gene expression
Baraz, L., Haupt, Y., Elkin, M., Peretz, T., & Vlodavsky, I. (2006) · Oncogene · doi:10.1038/sj.onc.1209425 · Cited by 98
Preclinical Models of Pediatric Solid Tumors (Neuroblastoma) and Their Use in Drug Discovery
Patterson, D., Shohet, J., & Kim, E. S. (2011) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1417s52 · Cited by 63
Self-citationTrans-activation of heparanase promoter by ETS transcription factors
Lu, W., Liu, Y. N., Kang, B.-B., & Chen, J. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206201 · Cited by 63
Zhang, L., Sullivan, P., Suyama, J. A., & Marchetti, D. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0375 · Cited by 55
Self-citationProteases as modulators of tumor–stromal interaction: Primary tumors to bone metastases
Wilson, T. J., & Singh, R. K. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.11.001 · Cited by 53
de Mestre, A. M., Staykova, M. A., Hornby, J. R., Willenborg, D. O., & Hulett, M. D. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507315 · Cited by 53
Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer
Zhang, L., Ngo, J. A., Wetzel, M. D., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2014.11.007 · Cited by 46
Post-transcriptional regulation of heparanase gene expression by a 3′ AU-rich element
Arvatz, G., Barash, U., Nativ, O., Ilan, N., & Vlodavsky, I. (2010) · The FASEB Journal · doi:10.1096/fj.10-156372 · Cited by 33
Ahmed, N. M., Brawley, V. S., Diouf, O., Anderson, P. M., Hicks, J. M., Wang, L. E., Dotti, G., Wels, W. S., Liu, H., Gee, A. P., et al. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-3500 · Cited by 8
Self-citation
Cited by
CAR-T cell therapy: current limitations and potential strategies
Sterner, R. C., & Sterner, R. M. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00459-7 · Cited by 2,926
‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
Depil, S., Duchateau, P., Grupp, S. A., Mufti, G., & Poirot, L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0051-2 · Cited by 1,227
Exploring treatment options in cancer: tumor treatment strategies
Liu, B., Zhou, H., Tan, L., Siu, K. T. H., & Guan, X.-Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01856-7 · Cited by 1,201
Immunological hallmarks of stromal cells in the tumour microenvironment
Turley, S. J., Cremasco, V., & Astarita, J. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3902 · Cited by 1,140
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Metadata
- Authors
- Caruana, I., Savoldo, B., Hoyos, V., Weber, G., Liu, H., Kim, E. S., Ittmann, M. M., Marchetti, D., & Dotti, G.
- Venue
- Nature Medicine
- Published
- 2015-04-13
- Volume
- 21
- Issue
- 5
- Pages
- 524-529
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2067319054
- Cited by
- 814
- References
- 33
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.